bpc 157 subq injection BPC-157 Peptide I have been reading about

The MitoPrime peptide vial is the NAD+/MOTS-c/5-Amino-1MQ research product

Format: Lyophilized Powder (Blend) Purity: 99% (HPLC Verified) Research Focus: Inflammatory Skin Conditions, Microbial Defense & Structural Repair

Preclinical studies have not identified toxic doses or lethal doses for BPC-157, and researchers reported no teratogenic, genotoxic, anaphylactic, or local toxic effects

Aydin 1 , Frank Te Nijenhuis 2 , Marta Rubiera 3 , Susanne Bonekamp 4 , Ronen R Leker 5 , Satoru Tanioka 1 , Theo van Walsum 2 , Charles Majoie 6 , Wim Van Zwam 7 , Sam Payabvash 8 , Thomas Tourdias 9 , Christian Nolte 10 , Dietmar Frey 1,11 1 CLAIM - Charit Lab for Artificial Intelligence in Medicine, Charit Universittsmedizin Berlin, Germany, Berlin, Germany, 2 Biomedical Imaging Group Rotterdam, Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands, 3 Department of Neurology, Vall dHebrn University Hospital, Barcelona, Spain, 4 Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany, 5 Stroke Unit, Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel, 6 Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, Netherlands, 7 Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, Netherlands, 8 Department of Radiology, Columbia University, New York, United States, 9 Department of Neuroradiology, CHU Pellegrin, Bordeaux, France, 10 ent of Neurology with Experimental Neurology and Center for Stroke Research Berlin (CSB), Charit Universittsmedizin Berlin, Berlin, Germany, 11 Department of Neurosurgery, Charit Universittsmedizin Berlin, Berlin, Germany Background and Aims: Modelling of prognosis has the potential to improve treatment decisions and establish precision medicine in ischemic stroke

they are searching for complete structural profiling